Skip to content

Study · Not a test of the peptide alone · 1995

2 results

Use of the gonadotropin-releasing hormone agonist triptorelin in the diagnosis of delayed puberty in boys.

Zamboni G, Antoniazzi F, Tatò L

The Journal of pediatrics1 May 1995Cited by 21 (Europe PMC)

PMID7752001 (opens in a new tab)DOI10.1016/s0022-3476(95)70406-x (opens in a new tab)PepBankPUB-07752001
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  1. 01HumanNot a test of Triptorelin (Trelstar, Decapeptyl) aloneObservational studyActivity measurement

    In teenage boys given a triptorelin test, the rise in gonadotropin was significantly greater in boys with delayed puberty than in boys with gonadotropin deficiency.

    In plain wordsIn teenage boys given a triptorelin test, gonadotropin levels rose more in boys with delayed puberty than in boys with gonadotropin deficiency.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    IncreaseGonadotropin increase
    Study

    n: not reported in source

    Comparator
    Boys with gonadotropin deficiency
    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Source sentences

    Summary
    The increase in blood gonadotropin and testosterone levels was significantly greater in patients with delayed puberty than in those with gonadotropin deficiency.
    2 context sentences
    Summary · context
    To differentiate gonadotropin deficiency from delayed puberty in teenage boys, 0.1 mg/m2 of triptorelin, a gonadotropin-releasing hormone agonist, was administered subcutaneously at 4 AM.
    Summary · context
    Serum gonadotropins and testosterone levels were determined at baseline and 4 hours after the injection.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  2. 02HumanNot a test of Triptorelin (Trelstar, Decapeptyl) aloneObservational studyActivity measurement

    In teenage boys given a triptorelin test, the rise in testosterone was significantly greater in boys with delayed puberty than in boys with gonadotropin deficiency.

    In plain wordsIn teenage boys given a triptorelin test, testosterone levels rose more in boys with delayed puberty than in boys with gonadotropin deficiency.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    IncreaseTestosterone increase
    Study

    n: not reported in source

    Comparator
    Boys with gonadotropin deficiency
    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Source sentences

    Summary
    The increase in blood gonadotropin and testosterone levels was significantly greater in patients with delayed puberty than in those with gonadotropin deficiency.
    2 context sentences
    Summary · context
    To differentiate gonadotropin deficiency from delayed puberty in teenage boys, 0.1 mg/m2 of triptorelin, a gonadotropin-releasing hormone agonist, was administered subcutaneously at 4 AM.
    Summary · context
    Serum gonadotropins and testosterone levels were determined at baseline and 4 hours after the injection.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.